HitGen Inc.

¥35.17As of Sun 8 Nov 2026, 12:00 UTC
SSE:688222Healthcare
Country China
PE (Fwd) •••
TSR 7Y CAGR 0.38%
Div yield 0.37%
ROE 10.13%
Biotechnology
Beta (5Y) 0.65
PE TTM 90.48
TSR TTM 40.09%
Mkt cap ¥14.09B
ROIC 20.90%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥43
23.31%
(44.20%)
Hold 12|0|11|11|3
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.85
0.95
1.04
1.00
36.40%
40.31%
40.16%
24.11%
Revenue¥M
789.7
775.2
807.9
816.7
1.90%
(2.67%)
(0.74%)
2.80%
Peers (US$2.112B)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.798
0.915
0.675
EBIT/Intx
1.717
0.131
0.136
Own earn%
(66.43)
(79.10)
(78.68)
Sh yield%
37.62
44.25
44.53
Owners
Insiders/Inst%
1.24
51.93
Short interest%
5.97
SBC / revenue%
0.56
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
24–30
$1 testx
—
Incr. ROIC%
2